Rating History for Reata Pharmaceuticals (RETA) by TD Cowen
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/1/2023 | Tyler Van Buren | Maintain | Buy (N/A) |
172.50 (140.00) |
|
Details | |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/1/2023 | Tyler Van Buren | Maintain | Buy (N/A) |
172.50 (140.00) |
|
Details | |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||